Skip to main content
Gut logoLink to Gut
. 2001 Mar;48(3):320–325. doi: 10.1136/gut.48.3.320

Genetically related Escherichia coli strains associated with Crohn's disease

E Masseret 1, J Boudeau 1, J Colombel 1, C Neut 1, P Desreumaux 1, B Joly 1, A Cortot 1, A Darfeuille-Michau 1
PMCID: PMC1760134  PMID: 11171820

Abstract

Escherichia coli strains isolated from patients with Crohn's disease (CD) with chronic ileal lesions (n=14), early endoscopic recurrent lesions (n=20), without endoscopic recurrence (n=7), and controls (n=21) were compared by ribotyping. The dendrogram generated by 50 ribotype profile analysis revealed a large cluster of genetically linked E coli strains isolated significantly more frequently from patients with chronic and recurrent CD (24/33 patients) than from controls (9/21) (p<0.05). Most patients operated on for chronic ileal lesions (78.5%) harboured E coli strains belonging to cluster A (p<0.002 v controls). The prevalence of patients with early recurrent lesions harbouring E coli strains belonging to this cluster was high but not significant, although 16 strains isolated from eight patients presented the same ribotype profile. In this cluster, 21 of 26 strains isolated from patients with active CD demonstrated adherent ability to differentiated Caco-2 cells, indicating that most of the genetically related strains share a common virulence trait. Comparison of E coli strains recovered from ulcerated and healthy mucosa of patients operated on for CD demonstrated in each patient that a single strain colonised the intestinal mucosa. Our results suggest that although a single E coli isolate was not found in Crohn's ileal mucosa, some genotypes were more likely than others to be associated with chronic or early recurrent ileal lesions.


Keywords: Escherichia coli; Crohn's disease; chronic ileal lesion; early endoscopic recurrent ileal lesion; ribotyping

Full Text

The Full Text of this article is available as a PDF (159.1 KB).

Figure 1  .

Figure 1  

Genetic relationships between Escherichia coli strains, as estimated by clustering analysis of rRNA gene restriction fragment length polymorphism data obtained after DNA digestion by HindIII. The 118 E coli strains analysed were isolated as follows: 41 strains from patients with Crohn's disease (CD) with early recurrent lesions (ER), 39 strains from CD patients with chronic ileal lesions (CIL), 15 strains from CD patients without endoscopic recurrence (CDH), and 23 strains isolated from ileal biopsy (IC) or stool specimens (SC) from controls.

Figure 2  .

Figure 2  

Ribotype profiles of Escherichia coli strains isolated from healthy and ulcerated mucosa. E coli strains were isolated from healthy (H) and ulcerated (U) mucosa from three patients operated on for Crohn's disease.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alos J. I., Lambert T., Courvalin P. Comparison of two molecular methods for tracing nosocomial transmission of Escherichia coli K1 in a neonatal unit. J Clin Microbiol. 1993 Jul;31(7):1704–1709. doi: 10.1128/jcm.31.7.1704-1709.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bingen E. H., Denamur E., Picard B., Goullet P., Lambert-Zechovsky N. Y., Brahimi N., Mercier J. C., Beaufils F., Elion J. Molecular epidemiology unravels the complexity of neonatal Escherichia coli acquisition in twins. J Clin Microbiol. 1992 Jul;30(7):1896–1898. doi: 10.1128/jcm.30.7.1896-1898.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Boudeau J., Glasser A. L., Masseret E., Joly B., Darfeuille-Michaud A. Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease. Infect Immun. 1999 Sep;67(9):4499–4509. doi: 10.1128/iai.67.9.4499-4509.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brosius J., Ullrich A., Raker M. A., Gray A., Dull T. J., Gutell R. R., Noller H. F. Construction and fine mapping of recombinant plasmids containing the rrnB ribosomal RNA operon of E. coli. Plasmid. 1981 Jul;6(1):112–118. doi: 10.1016/0147-619x(81)90058-5. [DOI] [PubMed] [Google Scholar]
  5. Bulois P., Desreumaux P., Neut C., Darfeuille-Michaud A., Cortot A., Colombel J. F. Infectious agents and Crohn's disease. Clin Microbiol Infect. 1999 Oct;5(10):601–604. doi: 10.1111/j.1469-0691.1999.tb00415.x. [DOI] [PubMed] [Google Scholar]
  6. Burke D. A., Axon A. T. Adhesive Escherichia coli in inflammatory bowel disease and infective diarrhoea. BMJ. 1988 Jul 9;297(6641):102–104. doi: 10.1136/bmj.297.6641.102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cartun R. W., Van Kruiningen H. J., Pedersen C. A., Berman M. M. An immunocytochemical search for infectious agents in Crohn's disease. Mod Pathol. 1993 Mar;6(2):212–219. [PubMed] [Google Scholar]
  8. Dalla-Costa L. M., Irino K., Rodrigues J., Rivera I. N., Trabulsi L. R. Characterisation of diarrhoeagenic Escherichia coli clones by ribotyping and ERIC-PCR. J Med Microbiol. 1998 Mar;47(3):227–234. doi: 10.1099/00222615-47-3-227. [DOI] [PubMed] [Google Scholar]
  9. Darfeuille-Michaud A., Neut C., Barnich N., Lederman E., Di Martino P., Desreumaux P., Gambiez L., Joly B., Cortot A., Colombel J. F. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology. 1998 Dec;115(6):1405–1413. doi: 10.1016/s0016-5085(98)70019-8. [DOI] [PubMed] [Google Scholar]
  10. Dickinson R. J., Varian S. A., Axon A. T., Cooke E. M. Increased incidence of faecal coliforms with in vitro adhesive and invasive properties in patients with ulcerative colitis. Gut. 1980 Sep;21(9):787–792. doi: 10.1136/gut.21.9.787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Giaffer M. H., Holdsworth C. D., Duerden B. I. Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel disease. Gut. 1992 May;33(5):646–650. doi: 10.1136/gut.33.5.646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Marchlewicz B., Spiewak M., Lampinen J. Evaluation of Abbott TESTPACK ROTAVIRUS with clinical specimens. J Clin Microbiol. 1988 Nov;26(11):2456–2458. doi: 10.1128/jcm.26.11.2456-2458.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Marshall S., Clark C. G., Wang G., Mulvey M., Kelly M. T., Johnson W. M. Comparison of molecular methods for typing Vibrio parahaemolyticus. J Clin Microbiol. 1999 Aug;37(8):2473–2478. doi: 10.1128/jcm.37.8.2473-2478.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Nataro J. P., Kaper J. B. Diarrheagenic Escherichia coli. Clin Microbiol Rev. 1998 Jan;11(1):142–201. doi: 10.1128/cmr.11.1.142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Parveen S., Portier K. M., Robinson K., Edmiston L., Tamplin M. L. Discriminant analysis of ribotype profiles of Escherichia coli for differentiating human and nonhuman sources of fecal pollution. Appl Environ Microbiol. 1999 Jul;65(7):3142–3147. doi: 10.1128/aem.65.7.3142-3147.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Picard-Pasquier N., Ouagued M., Picard B., Goullet P., Krishnamoorthy R. A simple, sensitive method of analyzing bacterial ribosomal DNA polymorphism. Electrophoresis. 1989 Mar;10(3):186–189. doi: 10.1002/elps.1150100306. [DOI] [PubMed] [Google Scholar]
  17. Rhodes J. M. Unifying hypothesis for inflammatory bowel disease and associated colon cancer: sticking the pieces together with sugar. Lancet. 1996 Jan 6;347(8993):40–44. doi: 10.1016/s0140-6736(96)91563-9. [DOI] [PubMed] [Google Scholar]
  18. Rutgeerts P., Geboes K., Vantrappen G., Beyls J., Kerremans R., Hiele M. Predictability of the postoperative course of Crohn's disease. Gastroenterology. 1990 Oct;99(4):956–963. doi: 10.1016/0016-5085(90)90613-6. [DOI] [PubMed] [Google Scholar]
  19. Schultsz C., Moussa M., van Ketel R., Tytgat G. N., Dankert J. Frequency of pathogenic and enteroadherent Escherichia coli in patients with inflammatory bowel disease and controls. J Clin Pathol. 1997 Jul;50(7):573–579. doi: 10.1136/jcp.50.7.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Shen W., Steinrück H., Ljungh A. Expression of binding of plasminogen, thrombospondin, vitronectin, and fibrinogen, and adhesive properties by Escherichia coli strains isolated from patients with colonic diseases. Gut. 1995 Mar;36(3):401–406. doi: 10.1136/gut.36.3.401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Smith J. M., Smith N. H., O'Rourke M., Spratt B. G. How clonal are bacteria? Proc Natl Acad Sci U S A. 1993 May 15;90(10):4384–4388. doi: 10.1073/pnas.90.10.4384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Sutherland L., Singleton J., Sessions J., Hanauer S., Krawitt E., Rankin G., Summers R., Mekhjian H., Greenberger N., Kelly M. Double blind, placebo controlled trial of metronidazole in Crohn's disease. Gut. 1991 Sep;32(9):1071–1075. doi: 10.1136/gut.32.9.1071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Tabaqchali S., O'Donoghue D. P., Bettelheim K. A. Escherichia coli antibodies in patients with inflammatory bowel disease. Gut. 1978 Feb;19(2):108–113. doi: 10.1136/gut.19.2.108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Tarkka E., Ahman H., Siitonen A. Ribotyping as an epidemiologic tool for Escherichia coli. Epidemiol Infect. 1994 Apr;112(2):263–274. doi: 10.1017/s0950268800057678. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Tysk C., Riedesel H., Lindberg E., Panzini B., Podolsky D., Järnerot G. Colonic glycoproteins in monozygotic twins with inflammatory bowel disease. Gastroenterology. 1991 Feb;100(2):419–423. doi: 10.1016/0016-5085(91)90211-3. [DOI] [PubMed] [Google Scholar]
  26. Wellmann W., Fink P. C., Benner F., Schmidt F. W. Endotoxaemia in active Crohn's disease. Treatment with whole gut irrigation and 5-aminosalicylic acid. Gut. 1986 Jul;27(7):814–820. doi: 10.1136/gut.27.7.814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Westerlund B., Korhonen T. K. Bacterial proteins binding to the mammalian extracellular matrix. Mol Microbiol. 1993 Aug;9(4):687–694. doi: 10.1111/j.1365-2958.1993.tb01729.x. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES